Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations
Clinical trial NCT02908269 · COMPLETED
Trial details
- NCT number
- NCT02908269
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2016-12-09
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.